Comorbidities in women living with HIV: A systematic review

S Raffe, C Sabin, Y Gilleece… - HIV …, 2022 - Wiley Online Library
Objectives Effective antiretroviral therapy (ART) has improved the life expectancy of women
living with HIV (WLWH). This population is now experiencing age‐related comorbidities …

[HTML][HTML] Diagnosis and treatment of leprosy reactions in integrated services-the patients' perspective in Nepal

SF Raffe, M Thapa, S Khadge, K Tamang… - PLoS neglected …, 2013 - journals.plos.org
Leprosy care has been integrated with peripheral health services, away from vertical
programmes. This includes the diagnosis and management of leprosy reactions, which …

The pharmacokinetics, pharmacodynamics and clinical efficacy of elvitegravir+ cobicistat+ emtricitabine+ tenofovir combination therapy for the treatment of HIV

S Raffe, M Fisher - Expert Opinion on Drug Metabolism & …, 2015 - Taylor & Francis
Introduction: Co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir
(EVG/COBI/FTC/TDF or StribildTM) is the latest antiretroviral tablet approved in the EU. This …

The management of HIV in pregnancy: A 10-year experience

SF Raffe, C Savage, LA Perry, A Patel, T Keith… - European Journal of …, 2017 - Elsevier
Objective The package of care to reduce HIV mother to child transmission (MTCT) has
evolved significantly since trials of ante and intrapartum antiretroviral therapy (ART) in 1994 …

Diagnostic tests for sexually transmitted infections

S Raffe, S Soni - Medicine, 2018 - Elsevier
The laboratory plays an essential role in the diagnosis of sexually transmitted infections
(STIs). The ability to make an accurate diagnosis is essential because of the individual and …

Female pelvic pain

S Raffe, G Dean - Medicine, 2022 - Elsevier
There are many different causes of female pelvic pain, some of which are life-threatening
while others have long-term implications for fertility. It can be difficult to identify the …

Research news in clinical context

S Raffe, W Tang, G Villa - 2023 - sti.bmj.com
The effect of pre-exposure prophylaxis (PrEP) use, on sexual behaviour and STI
transmission risk among men who have sex with men (MSM) is debated. Investigators in the …

Research news in clinical context

W Tang, S Raffe, B Aksak-Wąs, M Daskalopoulou - 2023 - sti.bmj.com
Sitafloxacin is a fourth-generation fluoroquinolone approved in Japan. An open-label
prospective study evaluated sitafloxacin monotherapy (200 mg daily for 7 days) for treating …

Research news in clinical context

M Daskalopoulou, G Villa, S Raffe, R Thomson-Glover - 2022 - sti.bmj.com
Single-tablet regimens enhance adherence and are considered optimum for children and
adolescents. 1 This open-label international single-arm trial enrolled 100 individuals aged 6 …

Research news in clinical context

S Rusconi, KE Shields, A Arias, S Raffe… - 2022 - sti.bmj.com
Treatment with Paxlovid (nirmatrelvir/ritonavir 300/100 mg two times per day for 5 days) is
expected to play an important role in patients with mildto-moderate COVID-19 who are at …